Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


11.12.2017

1 AJNR Am J Neuroradiol
1 Br J Neurosurg
1 Cancer
1 Cancer Res
1 Childs Nerv Syst
1 Clin Cancer Res
1 J Neurol
12 J Neurooncol
1 J Nucl Med
1 Neuro Oncol
1 Neuroradiology
2 Neurosurgery
1 PLoS One
1 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJNR Am J Neuroradiol

  1. ZAKHARI N, Taccone MS, Torres C, Chakraborty S, et al
    Diagnostic Accuracy of Centrally Restricted Diffusion in the Differentiation of Treatment-Related Necrosis from Tumor Recurrence in High-Grade Gliomas.
    AJNR Am J Neuroradiol. 2017 Dec 7. pii: ajnr.A5485. doi: 10.3174/ajnr.A5485.
    PubMed     Text format     Abstract available


    Br J Neurosurg

  2. MARCHESINI N, Soda C, Ricci UM, Sedia M, et al
    12 Years delayed postoperative spinal recurrence of craniopharyngioma. Case report and literature review.
    Br J Neurosurg. 2017 Dec 4:1-3. doi: 10.1080/02688697.2017.1406454.
    PubMed     Text format     Abstract available


    Cancer

  3. JHAVERI J, Liu Y, Chowdhary M, Buchwald ZS, et al
    Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high-risk grade 2 glioma: An analysis of the National Cancer Data Base.
    Cancer. 2017 Dec 4. doi: 10.1002/cncr.31158.
    PubMed     Text format     Abstract available


    Cancer Res

  4. ZAKARIA R, Platt-Higgins A, Rathi N, Radon M, et al
    T cell densities in brain metastases are associated with patient survival times and diffusion tensor MRI changes.
    Cancer Res. 2017 Dec 6. pii: 0008-5472.CAN-17-1720.
    PubMed     Text format     Abstract available


    Childs Nerv Syst

  5. MEHRVAR A, Tashvighi M, Hedayati Asl AA, Niktoreh-Mofrad N, et al
    Management and outcomes of treating pediatric medulloblastoma: an eight years' experience in an Iranian pediatric center.
    Childs Nerv Syst. 2017 Dec 6. pii: 10.1007/s00381-017-3672.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  6. JIN X, Jin X, Kim LJY, Dixit D, et al
    Inhibition of ID1-BMPR2 intrinsic signaling sensitizes glioma stem cells to differentiation therapy.
    Clin Cancer Res. 2017 Dec 5. pii: 1078-0432.CCR-17-1529.
    PubMed     Text format     Abstract available


    J Neurol

  7. MIYAUCHI JT, Tsirka SE
    Advances in immunotherapeutic research for glioma therapy.
    J Neurol. 2017 Dec 5. pii: 10.1007/s00415-017-8695.
    PubMed     Text format     Abstract available


    J Neurooncol

  8. ANTONSSON M, Longoni F, Jakola A, Tisell M, et al
    Pre-operative language ability in patients with presumed low-grade glioma.
    J Neurooncol. 2017 Dec 1. pii: 10.1007/s11060-017-2699.
    PubMed     Text format     Abstract available

  9. GOETHE E, Carter BZ, Rao G, Pemmaraju N, et al
    Glioblastoma and acute myeloid leukemia: malignancies with striking similarities.
    J Neurooncol. 2017 Dec 1. pii: 10.1007/s11060-017-2676.
    PubMed     Text format     Abstract available

  10. PICART T, Barritault M, Berthillier J, Meyronet D, et al
    Characteristics of cerebellar glioblastomas in adults.
    J Neurooncol. 2017 Dec 1. pii: 10.1007/s11060-017-2682.
    PubMed     Text format     Abstract available

  11. FANG P, Boehling NS, Koay EJ, Bucheit AD, et al
    Melanoma brain metastases harboring BRAF (V600K) or NRAS mutations are associated with an increased local failure rate following conventional therapy.
    J Neurooncol. 2017 Dec 2. pii: 10.1007/s11060-017-2695.
    PubMed     Text format     Abstract available

  12. LOBON-IGLESIAS MJ, Giraud G, Castel D, Philippe C, et al
    Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients?
    J Neurooncol. 2017 Dec 2. pii: 10.1007/s11060-017-2702.
    PubMed     Text format     Abstract available

  13. QIAN Z, Li Y, Fan X, Zhang C, et al
    Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas.
    J Neurooncol. 2017 Dec 4. pii: 10.1007/s11060-017-2704.
    PubMed     Text format     Abstract available

  14. KLINE C, Felton E, Allen IE, Tahir P, et al
    Survival outcomes in pediatric recurrent high-grade glioma: results of a 20-year systematic review and meta-analysis.
    J Neurooncol. 2017 Dec 4. pii: 10.1007/s11060-017-2701.
    PubMed     Text format     Abstract available

  15. BINGHAM B, Patel CG, Shinohara ET, Attia A, et al
    Utilization of hypofractionated radiotherapy in treatment of glioblastoma multiforme in elderly patients not receiving adjuvant chemoradiotherapy: A National Cancer Database Analysis.
    J Neurooncol. 2017 Dec 5. pii: 10.1007/s11060-017-2665.
    PubMed     Text format     Abstract available

  16. LAKOMKIN N, Hadjipanayis CG
    Non-routine discharge disposition is associated with post-discharge complications and 30-day readmissions following craniotomy for brain tumor resection.
    J Neurooncol. 2017 Dec 5. pii: 10.1007/s11060-017-2689.
    PubMed     Text format     Abstract available

  17. VENTURA LM, Grieco JA, Evans CL, Kuhlthau KA, et al
    Executive functioning, academic skills, and quality of life in pediatric patients with brain tumors post-proton radiation therapy.
    J Neurooncol. 2017 Dec 6. pii: 10.1007/s11060-017-2703.
    PubMed     Text format     Abstract available

  18. PRABHU RS, Press RH, Boselli DM, Miller KR, et al
    External validity of two nomograms for predicting distant brain failure after radiosurgery for brain metastases in a bi-institutional independent patient cohort.
    J Neurooncol. 2017 Dec 7. pii: 10.1007/s11060-017-2707.
    PubMed     Text format     Abstract available

  19. ROGERS TW, Toor G, Drummond K, Love C, et al
    The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas.
    J Neurooncol. 2017 Dec 7. pii: 10.1007/s11060-017-2710.
    PubMed     Text format     Abstract available


    J Nucl Med

  20. OYEN WJG, Jones C
    ImmunoPET in pontine glioma : more than meets the eye ?
    J Nucl Med. 2017 Dec 7. pii: jnumed.117.200527. doi: 10.2967/jnumed.117.200527.
    PubMed     Text format    


    Neuro Oncol

  21. PEYRE M, Gauchotte G, Giry M, Froehlich S, et al
    De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors.
    Neuro Oncol. 2017 Dec 5. pii: 4694050. doi: 10.1093.
    PubMed     Text format     Abstract available


    Neuroradiology

  22. RAZEK AAKA, El-Serougy L, Abdelsalam M, Gaballa G, et al
    Differentiation of residual/recurrent gliomas from postradiation necrosis with arterial spin labeling and diffusion tensor magnetic resonance imaging-derived metrics.
    Neuroradiology. 2017 Dec 7. pii: 10.1007/s00234-017-1955.
    PubMed     Text format     Abstract available


    Neurosurgery

  23. DASENBROCK HH, Yan SC, Smith TR, Valdes PA, et al
    Readmission After Craniotomy for Tumor: A National Surgical Quality Improvement Program Analysis.
    Neurosurgery. 2017;80:551-562.
    PubMed     Text format     Abstract available

  24. KNAPPE UJ, Jaspers C, Buschsieweke D, Reinbold WD, et al
    Ectopic Adrenocorticotropic Hormone-Secreting Pituitary Adenomas: An Underestimated Entity.
    Neurosurgery. 2016.
    PubMed     Text format     Abstract available


    PLoS One

  25. LIU H, Liu N, Cheng Y, Jin W, et al
    Hexokinase 2 (HK2), the tumor promoter in glioma, is downregulated by miR-218/Bmi1 pathway.
    PLoS One. 2017;12:e0189353.
    PubMed     Text format     Abstract available


    Radiology

  26. FALK DELGADO A, Nilsson M, van Westen D, Falk Delgado A, et al
    Glioma Grade Discrimination with MR Diffusion Kurtosis Imaging: A Meta-Analysis of Diagnostic Accuracy.
    Radiology. 2017 Dec 4:171315. doi: 10.1148/radiol.2017171315.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: